Jan 25 2010
The American Cancer Society’s Mid-South Division, LiDestri Foods, MDU
Resources Group, Inc. and WCA Hospital have received CEO Cancer Gold
Standard™ accreditation, recognizing the
commitment of these organizations to taking concrete actions to reduce
the cancer risk of employees and their families through screenings,
early detection, and healthy changes in lifestyle.
“do
something bold and venturesome about cancer within your own corporate
families.”
William C. Weldon, chairman and chief executive officer of Johnson &
Johnson, chairs the CEO Roundtable on Cancer, a nonprofit
organization of cancer-fighting CEOs who created the CEO Cancer Gold
Standard™, in collaboration with the National
Cancer Institute, many of its designated cancer centers, and leading
health non-profit organizations and professionals. Today, more than one
million employees and family members are benefiting from the vision and
leadership of employers who have chosen to become Gold Standard accredited.
“We are pleased to recognize the efforts of these organizations in the
fight against cancer, starting with improving the health and wellness of
their own employees,” said Weldon. “I hope the commitment demonstrated
by these organizations will encourage other employers, large and small,
to become Gold Standard accredited.”
The CEO Cancer Gold Standard™ calls for
companies to evaluate their health benefits and corporate culture and
take extensive, concrete actions in five key areas of health and
wellness to fight cancer in the workplace. To earn Gold Standard
accreditation, a company must establish programs to reduce cancer risk
by discouraging tobacco use; encouraging physical activity; promoting
healthy diet and nutrition; detecting cancer at its earliest stages; and
providing access to quality care, including participation in clinical
trials.
Other organizations joining the American Cancer Society’s Mid-South
Division, LiDestri Foods, MDU Resources (NYSE: MDU) and WCA Hospital in
championing this workplace-based effort to eliminate cancer as a public
health threat include: Aetna (NYSE: AET), Aldagen, the American Cancer
Society’s National Home Office, the American Legacy Foundation, the
American Society of Clincial Oncology, Aptuit, AstraZeneca (NYSE: AZN),
C-Change, CIGNA (NYSE: CI), Dana-Farber Cancer Institute, Duke Medicine,
Edelman, Enzon Pharmaceuticals (NASDAQ:ENZN), Fox Chase Cancer Center,
GlaxoSmithKline (NYSE: GSK), Hogan & Hartson, Independence Blue Cross &
Blue Shield, Jenner & Block, Johnson & Johnson (NYSE: JNJ), The Lance
Armstrong Foundation, M. D. Anderson Cancer Center, Millennium: The
Takeda Oncology Company, Meridian Health, Minot State University, H. Lee
Moffitt Cancer Center and Research Institute, The National Cancer
Institute, Novartis (NYSE: NVS), The Oncology Nursing Society, OSI
Pharmaceuticals (NASDAQ: OSIP), Pfizer (NYSE: PFE), PhRMA, PPD
(NASDAQ: PPDI), Pride, Inc., Quintiles Transnational, sanofi-aventis
(NYSE: SNY), SAS Institute, State Farm, The University of North Dakota,
US Oncology, Valeant Pharmaceuticals (NYSE: VRX), Vanderbilt-Ingram
Cancer Center, Virtua Health and The Wistar Institute.
SOURCE The CEO Roundtable on Cancer